Skip to main content

Advertisement

Log in

Oral Human Immunoglobulin for Children with Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study

  • Original Paper
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Immunoglobulin secretion onto mucosal surfaces is a major component of the mucosal immune system. We hypothesized that chronic gastrointestinal (GI) disturbances associated with autistic disorder (AD) may be due to an underlying deficiency in mucosal immunity, and that orally administered immunoglobulin would be effective in alleviating chronic GI dysfunction in these individuals. In this pilot study, twelve male subjects diagnosed with AD were evaluated using a GI severity index (GSI) while receiving daily dosing with encapsulated human immunoglobulin. Following eight weeks of treatment, 50% of the subjects met prespecified criteria for response in GI signs and symptoms and showed significant behavioral improvement as assessed by the Autism Behavior Checklist and parent and physician rated Clinical Global Impression of Improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Anthony, A., Bjarnason, I., Sigthorsson, G., Montgomery, S. M., Murch, S. H., & Thompson, M., et al. (2000). Faecal calprotectin levels correlate with acute inflammation in autistic enterocolitis. Gut, 46(Suppl II), A3.

    Google Scholar 

  • Arnold, L. E., Aman, M. G., Martin, A., Collier-Crespin, A., Vitiello, B., & Tierney, E., et al. (2000). Assessment in multisite randomized clinical trials of patients with autistic disorder: The Autism RUPP Network. Research Units on Pediatric Psychopharmacology. Journal of Autism and Developmental Disorders, 30(2), 99–111.

    Article  PubMed  Google Scholar 

  • Ashwood, P., Anthony, A., Pellicer, A. A., Torrente, F., Walker-Smith, J. A., & Wakefield, A. J. (2003). Intestinal lymphocyte populations in children with regressive autism: Evidence for extensive mucosal immunopathology. Journal of Clinical Immunology, 23(6), 504–517.

    Article  PubMed  Google Scholar 

  • Barnes, G. L., Doyle, L. W., Hewson, P. H., Knoches, A. M., McLellan, J. A., & Kitchen, W. H., et al. (1982). A randomised trial of oral gammaglobulin in low-birth-weight infants infected with rotavirus. Lancet, 1(8286), 1371–1373.

    Article  PubMed  Google Scholar 

  • Casswall, T. H., Hammarstrom, L., Veress, B., Nord, C. E., Bogstedt, A., & Brockstedt U., et al. (1996). Oral IgA–IgG treatment of chronic non-specific diarrhoea in infants and children. Acta Paediatrica, 85(9), 1126–1128.

    PubMed  Google Scholar 

  • Chez, M. G., Buchanan, C. P., Bagan, B. T., Hammer, M. S., McCarthy, K. S., & Ovrutskaya, I., et al. (2000). Secretin and autism: A two-part clinical investigation. Journal of Autism and Developmental Disorders, 30(2), 87–94.

    Article  PubMed  Google Scholar 

  • Comi, A. M., Zimmerman, A. W., Frye, V. H., Law, P. A., & Peeden, J. N. (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. Journal of Child Neurology, 14(6), 388–394.

    PubMed  Google Scholar 

  • Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134(5), 607–613.

    Article  PubMed  Google Scholar 

  • Dalakas, M. C. (1997). Intravenous immune globulin therapy for neurologic diseases. Annals of Internal Medicine, 126(9), 721–730.

    PubMed  Google Scholar 

  • Daniels, W. W., Warren, R. P., Odell, J. D., Maciulis, A., Burger, R. A., & Warren, W. L., et al. (1995). Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology, 32(3), 120–123.

    Article  PubMed  Google Scholar 

  • Eibl, M. M., Wolf, H. M., Furnkranz, H., & Rosenkranz, A. (1988). Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA–IgG feeding. New England Journal of Medicine, 319(1), 1–7.

    Article  PubMed  Google Scholar 

  • Furlano, R. I., Anthony, A., Day, R., Brown, A., McGarvey, L., & Thomson, M. A., et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. Journal of Pediatrics, 138(3), 366–372.

    Article  PubMed  Google Scholar 

  • Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn’s-disease activity. Lancet, 1(8167), 514.

    Article  PubMed  Google Scholar 

  • Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. Journal of Pediatrics, 135(5), 559–563.

    Article  PubMed  Google Scholar 

  • Horvath, K., & Perman, J. A. (2002). Autism and gastrointestinal symptoms. Current Gastroenterology Reports, 4(3), 251–258.

    PubMed  Google Scholar 

  • Hyams, J. S., Mandel, F., Ferry, G. D., Gryboski, J. D., Kibort, P. M., Kirschner B. S., et al. (1992). Relationship of common laboratory parameters to the activity of Crohn’s disease in children. Journal of Pediatric Gastroenterology and Nutrition, 14(2), 216–222.

    Article  PubMed  Google Scholar 

  • Jyonouchi, H., Sun, S., & Le, H. (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. Journal of Neuroimmunology, 120(1–2), 170–179.

    Article  PubMed  Google Scholar 

  • Kanfer, E. J., Abrahamson, G., Taylor, J., Coleman, J. C., & Samson, D. M. (1994). Severe rotavirus-associated diarrhoea following bone marrow transplantation: treatment with oral immunoglobulin. Bone Marrow Transplantation, 14(4), 651–652.

    PubMed  Google Scholar 

  • Kazatchkine, M. D., & Kaveri, S. V. (2001). Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. New England Journal of Medicine, 345(10), 747–755.

    Article  PubMed  Google Scholar 

  • Korvatska, E., Van de Water, J., Anders, T. F., Gershwin, M. E. (2002). Genetic and immunologic considerations in autism. Neurobiology of Disease, 9(2), 107–125.

    Article  PubMed  Google Scholar 

  • Krug, D. A., Arick, J., & Almond, P. (1980). Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. Journal of Child Psychology and Psychiatry, 21(3), 221–229.

    Article  PubMed  Google Scholar 

  • Krug, D. A., Arick, J., & Almond, P. (1993). Autism screening instrument for educational planning. Examiner’s manual (1st ed.). Austin, Texas: Pro-ed.

    Google Scholar 

  • Kuddo, T., Nelson, K. B. (2003). How common are gastrointestinal disorders in children with autism?. Current Opinion in Pediatrics, 15(3), 339–343.

    Article  PubMed  Google Scholar 

  • Lichtiger, S., Present, D. H., Kornbluth, A., Gelernt, I., Bauer, J., & Galler, G., et al. (1994). Cyclosporine in severe ulcerative colitis refractory to steroid therapy. New England Journal of Medicine, 330(26), 1841–1845.

    Article  PubMed  Google Scholar 

  • Melamed, I., Griffiths, A. M., & Roifman, C. M. (1991). Benefit of oral immune globulin therapy in patients with immunodeficiency and chronic diarrhea. Journal of Pediatrics, 119(3), 486–489.

    Article  PubMed  Google Scholar 

  • Melmed, R. D., Schneider, C. K., Fabes, R. A., Phillips, J., & Reichelt, K. (2000). Metabolic markers and gastrointestinal symptoms in children with autism and related disorders. Journal of Pediatric Gastroenterology and Nutrition, 31(Suppl 2), A116.

    Google Scholar 

  • Messahel, S., Pheasant, A. E., Pall, H., Ahmed-Choudhury, J., Sungum-Paliwal, R. S., & Vostanis, P. (1998). Urinary levels of neopterin and biopterin in autism. Neuroscience Letters, 241(1), 17–20.

    Article  PubMed  Google Scholar 

  • Molloy, C. A., & Manning-Courtney, P. (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165–171.

    Article  PubMed  Google Scholar 

  • Money, J., Bobrow, N. A., & Clarke, F. C. (1971). Autism and autoimmune disease: a family study. Journal of Autism and Childhood Schizophrenia, 1(2), 146–160.

    Article  PubMed  Google Scholar 

  • Myren, J., Bouchier, I. A., Watkinson, G., Softley, A., Clamp, S. E., & de Dombal, F. T. (1984). The O.M.G.E. Multinational Inflammatory Bowel Disease Survey 1976–1982. A further report on 2,657 cases. Scandinavian Journal of Gastroenterology. Supplement, 95, 1–27.

    PubMed  Google Scholar 

  • NIMH, (1985). CGI (Clinical Global Impression) scale. Psychopharmacology Bulletin, 21, 839–840.

    Google Scholar 

  • Piven, J. (1997). The biological basis of autism. Current Opinion in Neurobiology, 7(5), 708–712.

    Article  PubMed  Google Scholar 

  • Roberts, W., Weaver, L., Brian, J., Bryson, S., Emelianova, S., & Griffiths, A. M., et al. (2001). Repeated doses of porcine secretin in the treatment of autism: A randomized, placebo-controlled trial. Pediatrics, 107(5), E71.

    Article  PubMed  Google Scholar 

  • Schott, J. M., Harkness, K., Barnes, J., della Rocchetta, A. I., Vincent, A., & Rossor, M. N. (2003). Amnesia, cerebral atrophy, and autoimmunity. Lancet, 361(9365), 1266.

    Article  PubMed  Google Scholar 

  • Singh, V. K. (1996). Plasma increase of interleukin-12 and interferon-gamma. Pathological significance in autism. Journal of Neuroimmunology, 66(1–2), 143–145.

    Article  PubMed  Google Scholar 

  • Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997). Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology, 17(1), 88–90.

    Article  PubMed  Google Scholar 

  • Sweeten, T. L., Bowyer, S. L., Posey, D. J., Halberstadt, G. M., & McDougle, C. J. (2003). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics, 112(5), e420.

    Article  PubMed  Google Scholar 

  • Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2003). High blood monocyte counts and neopterin levels in children with autistic disorder. American Journal of Psychiatry, 160(9), 1691–1693.

    Article  PubMed  Google Scholar 

  • Szatmari, P., Jones, M. B., Zwaigenbaum, L., MacLean, J. E. (1998). Genetics of autism: Overview and new directions. Journal of Autism and Developmental Disorders, 28(5), 351–368.

    Article  PubMed  Google Scholar 

  • Takai, T. (2002). Roles of Fc receptors in autoimmunity. Nature Reviews Immunology, 2(8), 580–592.

    PubMed  Google Scholar 

  • Torrente, F., Anthony, A., Heuschkel, R. B., Thomson, M. A., Ashwood, P., & Murch, S. H. (2004). Focal-enhanced gastritis in regressive autism with features distinct from Crohn’s and Helicobacter pylori gastritis. American Journal of Gastroenterology, 99(4), 598–605.

    Article  PubMed  Google Scholar 

  • Torrente, F., Ashwood, P., Day, R., Machado, N., Furlano, R. I., & Anthony, A., et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375–382.

    Article  PubMed  Google Scholar 

  • Torres, A.R., Maciulis, A., & Odell, D. (2001). The association of MHC genes with autism. Frontiers in Bioscience, 6, D936–D943.

    PubMed  Google Scholar 

  • Vincent, A., Lily, O., & Palace, J. (1999). Pathogenic autoantibodies to neuronal proteins in neurological disorders. Journal of Neuroimmunology, 100(1–2), 169–180.

    Article  PubMed  Google Scholar 

  • Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M., Davies, S., et al. (2000). Enterocolitis in children with developmental disorders. American Journal of Gastroenterology, 95(9), 2285–2295.

    Article  PubMed  Google Scholar 

  • Warny, M., Fatimi, A., Bostwick, E. F., Laine, D. C., Lebel, F., & LaMont, J. T., et al. (1999). Bovine immunoglobulin concentrate—Clostridium difficile retains C. difficile toxin neutralising activity after passage through the human stomach and small intestine. Gut, 44(2), 212–217.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the subjects and parents for their participation in the study, the Southwest Autism Research and Resource Center for making its facility available during the study, and Janet Kirwan, RN and Monica McCabe, RN, OCN for their skill and dedication in ensuring that the study was conducted in compliance with the study protocol and regulatory guidelines. Funding for the study was provided by Protein Therapeutics, Inc.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James A. Ostrem.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schneider, C.K., Melmed, R.D., Barstow, L.E. et al. Oral Human Immunoglobulin for Children with Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study. J Autism Dev Disord 36, 1053–1064 (2006). https://doi.org/10.1007/s10803-006-0141-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-006-0141-y

Keywords

Navigation